We seek to overcome the major challenges in drug discovery and development with our in silico drug design platform.

Terrence F. Blaschke is Professor Emeritus of Medicine and Molecular Pharmacology at Stanford University, Adjunct Professor of Biopharmaceutical Sciences at UCSF, and Adjunct Professor of Medicine at Indiana University. Dr. Blaschke is a past president of the American Society for Clinical Pharmacology and Therapeutics and the recipient of the Rawls-Palmer award, the Henry W Elliott award, and the Oscar B. Hunter award from ASCPT. He is former Chair of the USFDA’s Generic Drugs Advisory and Nonprescription Drugs Advisory Committees, and chaired the USP’s Drug Utilization Review Panel from 1995-2000. He was an original member of the AIDS Clinical Trials Group, and has also served on ACTG’s Pharmacology and Executive Committees. Dr. Blaschke has authored over 170 publications and is Associate Editor of the Annual Review of Pharmacology and Toxicology. He earned a M.D. from Columbia University, completed his residency at UCLA, and fellowship at UCSF before joining the Stanford faculty in 1974.